Ionis Pharmaceuticals Inc (NAS:IONS)
$ 38.27 -0.53 (-1.37%) Market Cap: 5.59 Bil Enterprise Value: 4.90 Bil PE Ratio: 0 PB Ratio: 18.85 GF Score: 70/100

Ionis Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2022 / 06:15PM GMT
Release Date Price: $48.66 (+3.89%)
Andrew Francis Galler
Morgan Stanley, Research Division - Equity Analyst

Good afternoon, everyone. I'm Andrew Galler, one of the biotech analysts here at Morgan Stanley. And I'm joined today by Brett Monia, CEO of Ionis Pharmaceuticals. So to start off, I'll read our disclosure statement. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

Questions & Answers

Andrew Francis Galler
Morgan Stanley, Research Division - Equity Analyst

So Brett, I wanted to kick it off just, you've been in this role a little over 30 months now. So I want to understand how your vision for Ionis has evolved in your opinion to the company and the direction forward?

Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, CEO & Director

Thank you, Andrew, and thanks for the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot